Salsalate reduces atherosclerosis through AMPKβ1 in mice
Objective: Salsalate is a prodrug of salicylate that lowers blood glucose in people with type 2 diabetes. AMP-activated protein kinase (AMPK) is an αβγ heterotrimer which inhibits macrophage inflammation and the synthesis of fatty acids and cholesterol in the liver through phosphorylation of acetyl-...
Saved in:
Main Authors: | Emily A. Day (Author), Rebecca J. Ford (Author), Brennan K. Smith (Author), Vanessa P. Houde (Author), Stephanie Stypa (Author), Sonia Rehal (Author), Sarka Lhotak (Author), Bruce E. Kemp (Author), Bernardo L. Trigatti (Author), Geoff H. Werstuck (Author), Richard C. Austin (Author), Morgan D. Fullerton (Author), Gregory R. Steinberg (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
by: Man K.S. Lee, et al.
Published: (2022) -
Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model
by: Martina Hüttl, et al.
Published: (2023) -
Evaluating the efficacy of Salsalate on prediabetic and diabetic patients with fatty liver: A randomized clinical trial
by: Elham Faghihimani, et al.
Published: (2013) -
The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice
by: Katarina Marcinko, et al.
Published: (2015) -
Preventive Role of Salsalate in Diabetes Is Associated With Reducing Intestinal Inflammation Through Improvement of Gut Dysbiosis in ZDF Rats
by: Xinrong Zhang, et al.
Published: (2020)